Related Experiment Video
Updated: Apr 27, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
A novel reannotation strategy for dissecting DNA methylation patterns of human long intergenic non-coding RNAs in
Hui Zhi1, Shangwei Ning1, Xiang Li1
1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.
Abstract:
Despite growing consensus that long intergenic non-coding ribonucleic acids (lincRNAs) are modulators of cancer, the knowledge about the deoxyribonucleic acid (DNA) methylation patterns of lincRNAs in cancers remains limited. In this study, we constructed DNA methylation profiles for 4629 tumors and 705 normal tissue samples from 20 different types of human cancer by reannotating data of DNA methylation arrays. We found that lincRNAs had different promoter methylation patterns in cancers. We classified 2461 lincRNAs into two categories and three subcategories, according to their promoter methylation patterns in tumors. LincRNAs with resistant methylation patterns in tumors had conserved transcriptional regulation regions and were ubiquitously expressed across normal tissues. By integrating cancer subtype data and patient clinical information, we identified lincRNAs with promoter methylation patterns that were associated with cancer status, subtype or prognosis for several cancers. Network analysis of aberrantly methylated lincRNAs in cancers showed that lincRNAs with aberrant methylation patterns might be involved in cancer development and progression. The methylated and demethylated lincRNAs identified in this study provide novel insights for developing cancer biomarkers and potential therapeutic targets.
Insights
This study reveals distinct deoxyribonucleic acid (DNA) methylation patterns in long intergenic non-coding ribonucleic acids (lincRNAs) across various cancers. These findings offer new avenues for developing cancer biomarkers and therapeutic targets.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Long intergenic non-coding ribonucleic acids (lincRNAs) are increasingly recognized as cancer modulators.
- However, their deoxyribonucleic acid (DNA) methylation patterns in cancer remain underexplored.
Purpose of the Study:
- To comprehensively profile DNA methylation patterns of lincRNAs in diverse human cancers.
- To identify lincRNAs with aberrant methylation associated with cancer status, subtype, and prognosis.
- To explore the role of aberrantly methylated lincRNAs in cancer development.
Main Methods:
- Reannotation of DNA methylation array data from 4629 tumors and 705 normal tissues across 20 cancer types.
- Classification of lincRNAs based on promoter methylation patterns.
- Integration of cancer subtype and clinical data.
- Network analysis of aberrantly methylated lincRNAs.
Main Results:
- Identified distinct promoter methylation patterns for lincRNAs in cancer compared to normal tissues.
- Classified 2461 lincRNAs into categories based on methylation patterns, with some showing conserved regulatory regions and ubiquitous expression in normal tissues.
- Discovered associations between lincRNA promoter methylation patterns and cancer status, subtype, or prognosis in several cancer types.
- Network analysis suggested involvement of aberrantly methylated lincRNAs in cancer progression.
Conclusions:
- Aberrant DNA methylation of lincRNAs is a significant feature across multiple human cancers.
- Methylated and demethylated lincRNAs identified represent potential novel biomarkers for cancer detection and patient stratification.
- These lincRNAs may also serve as promising therapeutic targets for cancer treatment.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Non-LTR Retrotransposons

